FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386243952> ?p ?o ?g. }

• W4386243952 endingPage "e1605" @default.
• W4386243952 startingPage "e1594" @default.
• W4386243952 abstract "Ocular myasthenia gravis (OMG) is an autoimmune disorder resulting in ocular symptoms such as diplopia and ptosis. The proportion of patients who convert to secondary generalised myasthenia gravis (SGMG) reported in the literature has been varied. The aim of this systematic review was to determine the clinical characteristics of patients with OMG and determine on the proportion of SGMG conversion.We conducted an electronic database search for randomised controlled trials, prospective non-randomised studies, observational studies and retrospective studies in EMBASE, CENTRAL, MEDLINE and Web of Science. We included studies with patients with OMG who initially presented with ocular symptoms and signs only who were seen in clinical practice, reporting on characteristics and the outcomes of SGMG. We excluded studies with paediatric and congenital myasthenia gravis populations. Eligibile studies included articles written in any language and containing data on patients with OMG. Main outcome measured was the proportion of patients with OMG who converted to SGMG and risk factors associated with secondary generalisation of OMG. Two independent reviewers screened titles and abstracts and extracted data from full texts, reporting findings according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Methodology was evaluated using the Joanna Briggs Institute critical appraisal forms. PROSPERO registration number: CRD2021285257 RESULTS: 31 studies were included in the quantitative and qualitative analysis. The proportion of generalisation ranged from 11 to 84%. The pooled proportion was 39% (95% CI 32%, 47%, I2=95·86%, p<0·001 unweighted, low certainty). Pooled risk ratio of female gender for conversion to SGMG was 1.06 (95%CI 0·96,1·17, I2=0% p=0·614, 21 studies included, very low certainty) and pooled risk ratio of AChR positivity was 1·30 (95%CI 1·05,1·56, I2=0% p=0·455, 16 studies included, very low certainty).Risk factors such as female gender and anti-AChR positivity have been identified as possible associations with SGMG but there are not enough quality observational studies. There is a need for a prospective global database of OMG patients, including all countries with different populations." @default.
• W4386243952 created "2023-08-30" @default.
• W4386243952 creator A5035553510 @default.
• W4386243952 creator A5061059985 @default.
• W4386243952 creator A5074050378 @default.
• W4386243952 date "2023-10-17" @default.
• W4386243952 modified "2023-10-18" @default.
• W4386243952 title "Clinical Characteristics Associated With Secondary Generalization in Ocular Myasthenia Gravis Patients: A Systematic Review and Meta-analysis" @default.
• W4386243952 cites W1247968195 @default.
• W4386243952 cites W1534349227 @default.
• W4386243952 cites W1974838611 @default.
• W4386243952 cites W1991201329 @default.
• W4386243952 cites W1992225474 @default.
• W4386243952 cites W1994038674 @default.
• W4386243952 cites W2015385567 @default.
• W4386243952 cites W2041684666 @default.
• W4386243952 cites W2042968563 @default.
• W4386243952 cites W2051701525 @default.
• W4386243952 cites W2062978230 @default.
• W4386243952 cites W2089117937 @default.
• W4386243952 cites W2098923148 @default.
• W4386243952 cites W2105321265 @default.
• W4386243952 cites W2136714722 @default.
• W4386243952 cites W2156098321 @default.
• W4386243952 cites W2158122370 @default.
• W4386243952 cites W2274988195 @default.
• W4386243952 cites W2312452396 @default.
• W4386243952 cites W2364450135 @default.
• W4386243952 cites W2417616718 @default.
• W4386243952 cites W2607192280 @default.
• W4386243952 cites W2659815784 @default.
• W4386243952 cites W2755762791 @default.
• W4386243952 cites W2761621565 @default.
• W4386243952 cites W2787901111 @default.
• W4386243952 cites W2806187231 @default.
• W4386243952 cites W2806319289 @default.
• W4386243952 cites W2904773280 @default.
• W4386243952 cites W2913761737 @default.
• W4386243952 cites W2944466772 @default.
• W4386243952 cites W2975901834 @default.
• W4386243952 cites W2978341907 @default.
• W4386243952 cites W2991792334 @default.
• W4386243952 cites W3006331137 @default.
• W4386243952 cites W3016760547 @default.
• W4386243952 cites W3035240339 @default.
• W4386243952 cites W3085009276 @default.
• W4386243952 cites W3128818525 @default.
• W4386243952 cites W3140876335 @default.
• W4386243952 cites W3160870656 @default.
• W4386243952 cites W4220927379 @default.
• W4386243952 cites W4224309467 @default.
• W4386243952 cites W4233026002 @default.
• W4386243952 cites W4292883630 @default.
• W4386243952 cites W4296519904 @default.
• W4386243952 cites W992550965 @default.
• W4386243952 doi "https://doi.org/10.1212/wnl.0000000000207642" @default.
• W4386243952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37643888" @default.
• W4386243952 hasPublicationYear "2023" @default.
• W4386243952 type Work @default.
• W4386243952 citedByCount "0" @default.
• W4386243952 crossrefType "journal-article" @default.
• W4386243952 hasAuthorship W4386243952A5035553510 @default.
• W4386243952 hasAuthorship W4386243952A5061059985 @default.
• W4386243952 hasAuthorship W4386243952A5074050378 @default.
• W4386243952 hasConcept C126322002 @default.
• W4386243952 hasConcept C141071460 @default.
• W4386243952 hasConcept C17744445 @default.
• W4386243952 hasConcept C187212893 @default.
• W4386243952 hasConcept C189708586 @default.
• W4386243952 hasConcept C199539241 @default.
• W4386243952 hasConcept C23131810 @default.
• W4386243952 hasConcept C2777960172 @default.
• W4386243952 hasConcept C2778105408 @default.
• W4386243952 hasConcept C2779473830 @default.
• W4386243952 hasConcept C2780581723 @default.
• W4386243952 hasConcept C2781194658 @default.
• W4386243952 hasConcept C71924100 @default.
• W4386243952 hasConcept C95190672 @default.
• W4386243952 hasConceptScore W4386243952C126322002 @default.
• W4386243952 hasConceptScore W4386243952C141071460 @default.
• W4386243952 hasConceptScore W4386243952C17744445 @default.
• W4386243952 hasConceptScore W4386243952C187212893 @default.
• W4386243952 hasConceptScore W4386243952C189708586 @default.
• W4386243952 hasConceptScore W4386243952C199539241 @default.
• W4386243952 hasConceptScore W4386243952C23131810 @default.
• W4386243952 hasConceptScore W4386243952C2777960172 @default.
• W4386243952 hasConceptScore W4386243952C2778105408 @default.
• W4386243952 hasConceptScore W4386243952C2779473830 @default.
• W4386243952 hasConceptScore W4386243952C2780581723 @default.
• W4386243952 hasConceptScore W4386243952C2781194658 @default.
• W4386243952 hasConceptScore W4386243952C71924100 @default.
• W4386243952 hasConceptScore W4386243952C95190672 @default.
• W4386243952 hasIssue "16" @default.
• W4386243952 hasLocation W43862439521 @default.
• W4386243952 hasLocation W43862439522 @default.
• W4386243952 hasOpenAccess W4386243952 @default.
• W4386243952 hasPrimaryLocation W43862439521 @default.
• W4386243952 hasRelatedWork W2064228077 @default.

• next